IL-33 contributes to disease severity in Psoriasis-like models of mouse

Cytokine. 2019 Jul:119:159-167. doi: 10.1016/j.cyto.2019.02.019. Epub 2019 Mar 23.

Abstract

Immune cells infiltrating the psoriatic skin secrete high amounts of pro-inflammatory cytokines IL-17, TNF-α, IL-21 and IL-36 resulting in chronic inflammation. However, the exact cellular and molecular mechanisms have not been fully understood. We report here elevation of IL-33 expression in psoriatic lesions. Studies in imiquimod (IMQ)-induced mice with psoriatic inflammation confirmed a critical role for IL-33 in driving the disease. IL-33 reduces the CD4+ and CD8+ cells, inhibits autophagy in IMQ-treated mouse skin, and promoted tyrosyl phosphorylation of STAT3. Thus, IL-33 appears to be a major risk factor for severity of psoriasis-like skin inflammation. Our findings may open new perspectives for understanding the mechanisms and developing a therapeutic strategy for psoriasis.

Keywords: Autophagy; HaCaT cell; Interleukin-33; Psoriasis-like skin inflammation; STAT3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD4-Positive T-Lymphocytes / metabolism
  • CD8-Positive T-Lymphocytes / metabolism
  • Cell Line
  • Cytokines / metabolism
  • Disease Models, Animal
  • Female
  • Humans
  • Imiquimod / therapeutic use
  • Inflammation / metabolism
  • Interleukin-17 / metabolism
  • Interleukin-33 / metabolism*
  • Interleukins / metabolism
  • Mice
  • Mice, Inbred BALB C
  • Psoriasis / chemically induced
  • Psoriasis / metabolism*
  • STAT3 Transcription Factor / metabolism
  • Skin / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Cytokines
  • IL33 protein, human
  • Il33 protein, mouse
  • Interleukin-17
  • Interleukin-33
  • Interleukins
  • STAT3 Transcription Factor
  • Tumor Necrosis Factor-alpha
  • interleukin-21
  • Imiquimod